Workflow
Arcutis Biotherapeutics (NasdaqGS:ARQT) FY Conference Transcript

Arcutis Biotherapeutics (NasdaqGS:ARQT) FY Conference September 09, 2025 02:35 PM ET Company ParticipantsFrank Watanabe - President, CEO & DirectorLatha Vairavan - CFOTodd Edwards - CCOConference Call ParticipantsJudah Frommer - Executive Director & Senior Equity Research AnalystJudah FrommerOkay. All right. Welcome everyone to this session of the Morgan Stanley Global Healthcare Conference. I'm Judah Frommer. Before I welcome the team from Arcutis Biotherapeutics, I'll just read a quick disclosure statemen ...